Cash Position and Capital Allocation
Net cash provided by operating activities of $196.9 million for the quarter ended September 30, 2021 compared to $111.6 million for the quarter ended September 30, 2020. The year-over-year increase in net cash provided by operating activities was largely due to an increase in cash collected resulting from higher revenues, which was partially offset by an increase in compensation-related costs and other operating expenses compared to the prior year quarter.
Cash and cash equivalents of $342.5 million at September 30, 2021 compared to $304.7 million at September 30, 2020 and $256.9 million at June 30, 2021. Total debt, net of cash, of ($1.3) million at September 30, 2021 improved compared to $36.6 million at September 30, 2020 and $159.4 million at June 30, 2021. The sequential decrease in total debt, net of cash, was primarily due to an increase in cash and cash equivalents and repayment of borrowings under the Company’s senior secured bank revolving credit facility.
There were no share repurchases during the quarter ended September 30, 2021. As of September 30, 2021, approximately $167.1 million remained available for common stock repurchases under the Company’s stock repurchase authorization.
Third Quarter 2021 Segment Results
Corporate Finance & Restructuring
Revenues in the Corporate Finance & Restructuring segment increased $13.7 million, or 5.8%, to $250.3 million in the quarter, compared to $236.6 million in the prior year quarter. Excluding the estimated positive impact from FX, revenues increased $10.1 million, or 4.3%, due to higher demand for transactions and business transformation services, which was partially offset by lower demand for restructuring services compared to the prior year quarter. Adjusted Segment EBITDA of $55.6 million, or 22.2% of segment revenues, compared to $56.2 million, or 23.8% of segment revenues, in the prior year quarter. The decrease in Adjusted Segment EBITDA was primarily due to higher compensation, which includes the impact of a 6.0% increase in billable headcount, and higher SG&A expenses compared to the prior year quarter.
Forensic and Litigation Consulting
Revenues in the Forensic and Litigation Consulting segment increased $26.2 million, or 22.0%, to $145.3 million in the quarter, compared to $119.1 million in the prior year quarter. Excluding the estimated positive impact from FX, revenues increased $24.9 million, or 20.9%. Acquisition-related revenues contributed $3.7 million in the quarter. Excluding the estimated positive impact from FX and acquisition-related revenues, revenues increased $21.3 million, or 17.8%, primarily due to higher demand for investigations, disputes and health solutions services. Adjusted Segment EBITDA of $16.6 million, or 11.4% of segment revenues, compared to $13.6 million, or 11.4% of segment revenues, in the prior year quarter. The increase in Adjusted Segment EBITDA was due to higher revenues, which was partially offset by higher compensation, which includes the impact of a 7.7% increase in billable headcount, and higher SG&A expenses compared to the prior year quarter.
Economic Consulting
Revenues in the Economic Consulting segment increased $17.6 million, or 11.3%, to $172.5 million in the quarter, compared to $155.0 million in the prior year quarter. Excluding the estimated positive impact from FX, revenues increased $14.9 million, or 9.6%, primarily due to higher demand for non-merger and acquisition (“M&A”)-related antitrust and financial economics services, which was partially offset by lower demand for M&A-related antitrust services compared to the prior year quarter. Adjusted Segment EBITDA of $29.9 million, or 17.3% of segment revenues, compared to $25.7 million, or 16.6% of segment revenues, in the prior year quarter. The increase in Adjusted Segment EBITDA was due to higher revenues, which was partially offset by higher compensation, which includes the impact of a 5.1% increase in billable headcount compared to the prior year quarter.